JPS55136233A - Hb peptide vaccine - Google Patents

Hb peptide vaccine

Info

Publication number
JPS55136233A
JPS55136233A JP4405879A JP4405879A JPS55136233A JP S55136233 A JPS55136233 A JP S55136233A JP 4405879 A JP4405879 A JP 4405879A JP 4405879 A JP4405879 A JP 4405879A JP S55136233 A JPS55136233 A JP S55136233A
Authority
JP
Japan
Prior art keywords
hepatitis
hbsag
virus
surface antigen
antigenicity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP4405879A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6212238B2 (th
Inventor
Hiroyuki Shiraishi
Riyouichi Shirochi
Nakao Ishida
Satoru Funakoshi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
GC Biopharma Corp
Original Assignee
Green Cross Corp Japan
Green Cross Corp Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Japan, Green Cross Corp Korea filed Critical Green Cross Corp Japan
Priority to JP4405879A priority Critical patent/JPS55136233A/ja
Publication of JPS55136233A publication Critical patent/JPS55136233A/ja
Publication of JPS6212238B2 publication Critical patent/JPS6212238B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
JP4405879A 1979-04-11 1979-04-11 Hb peptide vaccine Granted JPS55136233A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4405879A JPS55136233A (en) 1979-04-11 1979-04-11 Hb peptide vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4405879A JPS55136233A (en) 1979-04-11 1979-04-11 Hb peptide vaccine

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP628688A Division JPS63239234A (ja) 1988-01-14 1988-01-14 ワクチン製剤

Publications (2)

Publication Number Publication Date
JPS55136233A true JPS55136233A (en) 1980-10-23
JPS6212238B2 JPS6212238B2 (th) 1987-03-17

Family

ID=12681007

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4405879A Granted JPS55136233A (en) 1979-04-11 1979-04-11 Hb peptide vaccine

Country Status (1)

Country Link
JP (1) JPS55136233A (th)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60258127A (ja) * 1984-06-04 1985-12-20 Green Cross Corp:The Ｂ型肝炎ワクチンの製造方法
WO1995015497A1 (en) * 1993-11-30 1995-06-08 The University Of Queensland Immunoassay for cervical cancer

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JOUNAL OF VIROLOGY=1972 *
PROC NATL ACAD SCI USA=1977 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60258127A (ja) * 1984-06-04 1985-12-20 Green Cross Corp:The Ｂ型肝炎ワクチンの製造方法
WO1995015497A1 (en) * 1993-11-30 1995-06-08 The University Of Queensland Immunoassay for cervical cancer

Also Published As

Publication number Publication date
JPS6212238B2 (th) 1987-03-17

Similar Documents

Publication Publication Date Title
US4591505A (en) Process for inactivating hepatitis B virus
US4481189A (en) Process for preparing sterilized plasma and plasma derivatives
ATE125821T1 (de) Vakzin gegen hepatitis b.
PT101052A (pt) Proteinas hibridas uteis na preparacao de vacinas
WO1992017493A3 (en) Peptides and mixtures thereof for detecting antibodies to hepatitis c virus (hcv)
DE3381472D1 (de) Hepatitis-b-virus-gen enthaltende rekombinante dns, mit der klonierten viralen dns transformierte saeugetierzellen und herstellung von hepatitis-b-virusproteinen.
Fricke et al. Viral safety of clotting factor concentrates
DK57284A (da) Fremgangsmaade til inaktivering af et lipidvirus
JPS55136233A (en) Hb peptide vaccine
EP0198299A3 (en) A process for preparing hepatitis b surface antigen containing particles in novel forms which are highly immunogenic
JPS55136234A (en) Hb glycopeptide vaccine
KR920004422A (ko) Hiv의 주요 중화 결정인자
EP0967223A3 (de) Hepatitis C Virus Peptidantigene und Verfahren zur Bestimung von Hepatitis C Virus (HCV)
Stephan et al. Modulation of hepatitis B infection by intravenous application of an immunoglobulin preparation that contains antibodies to hepatitis B e and core antigens but not to hepatitis B surface antigen
ATE175445T1 (de) Verfahren zur gewinnung von rekombinantem hepatitis b virus (hep b) oberflächeantigen
US4946676A (en) Vaccine comprising an immunogenic protein and, as an adjuvant, a substantially non-immunogenic, sequentially homologous peptide
Dreesman et al. Immunization of chimpanzees with hepatitis B virus-derived polypeptides
RU2007106900A (ru) Иммуногенные комплексы, способ их приготовления и их применение в фармацевтических композициях
Feitelson The Molecular Components of Hepatitis B Virus
DK257887D0 (da) Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden
JPS51118825A (en) A process for preparing heat stable iga and igm
KR950704494A (ko) 수두-대상포진 바이러스(vzv)에 대한 백신(vaccines against varicellazoster virus(vzv))
EP0485347A3 (en) Recombinant hepatitis delta antigen, process for the purification and use thereof
Leboulleux et al. Loss of anti-HBc antibodies after HBV infection in immunized Senegalese children
Sobeslavsky Strategies for prevention and control of hepatitis B and hepatocellular carcinoma